The 2022 world health organization reevaluation of human and mammalian toxic equivalency factors for polychlorinated dioxins, dibenzofurans and biphenyls
Michael J. DeVito(National Institute of Environmental Health Sciences), Martin van den Berg(Utrecht University), Keiko Nohara(National Institute for Environmental Studies), Martin Rose, Karin van Ede, Stephen Safe(Texas A&M University), L.A.P. Hoogenboom(Wageningen University & Research), Bas Bokkers(National Institute for Public Health and the Environment), Cynthia V. Rider(National Institutes of Health), Richard E. Peterson(University of Münster), Matthew W. Wheeler(National Institute of Environmental Health Sciences), Majorie B.M. van Duursen(Vrije Universiteit Amsterdam), Daniele Wikoff(BioStrategies (United States)), Sean W. Kennedy(University of Ottawa), Bin Zhao(Northwestern Polytechnical University), Laurie C. Haws, Elsa Antunes Fernandes Gáspár, Dieter Schrenk(University of Kaiserslautern), Kim Petersen(World Health Organization), Mark Feeley
Cited by 111
Related Papers
Exactly the Same but Different: Promiscuity and Diversity in the Molecular Mechanisms of Action of the Aryl Hydrocarbon (Dioxin) Receptor
|Toxicological Sciences|2011|753
<i>In Vitro</i> Biologic Activities of the Antimicrobials Triclocarban, Its Analogs, and Triclosan in Bioassay Screens: Receptor-Based Bioassay Screens
|Environmental Health Perspectives|2008|349
Microbiome-Derived Tryptophan Metabolites and Their Aryl Hydrocarbon Receptor-Dependent Agonist and Antagonist Activities
|Molecular Pharmacology|2014|337
Guidance on risk assessment of nanomaterials to be applied in the food and feed chain: human and animal health
|EFSA Journal|2021|336
CH223191 Is a Ligand-Selective Antagonist of the Ah (Dioxin) Receptor
|Toxicological Sciences|2010|314